Evidence map›Paper›PMID 40942746›Full record

ArticleSensors (Basel, Switzerland)2025

Development of a Dynamic Path Planning System for Autonomous Mobile Robots Using a Multi-Agent System Approach.

Bradley Fourie, Louis Louw, Günter Bitsch

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bradley FourieDepartment of Industrial Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.
Louis LouwDepartment of Industrial Engineering, Stellenbosch University, Stellenbosch 7600, South Africa.ORCID 0000-0001-9789-5661
Günter BitschNXT Nachhaltigkeit und Technologie, Reutlingen University, 72762 Reutlingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autonomous Mobile Robots (AMRs) are increasingly important in Industry 4.0 intralogistics but creating path planning systems that adapt to dynamic and uncertain Flexible Manufacturing Systems (FMS), especially managing conflicts among multiple AMRs with a need for scalable decentralised solutions, remains a significant challenge. This research introduces a dynamic path planning system for AMRs designed for reactive adaptation to FMS disturbances and generalisation across factory layouts, incorporating support for multiple AMRs with integrated conflict avoidance. The system is built on a Multi-Agent Systems (MAS) architecture, where software AMR agents independently calculate their paths using a hybrid Genetic Algorithm (GA) that employs Cell-Based Decomposition (CBD) and optimises path length, smoothness, and overlap via a multi-objective fitness function. Multi-AMR conflict avoidance is implemented using the Iterative Exclusion Principle (IEP), which facilitates priority-based planning, knowledge sharing through Predictive Collision Avoidance (PCA), and iterative replanning among agents communicating via a blackboard agent. Verification demonstrated the system's ability to successfully avoid deadlocks for up to nine AMRs and exhibit good scalability. Validation in a simulated FMS environment confirmed robust adaptation to various disturbances, including static and dynamic obstacles, while maintaining stable run times and consistent path quality. These results affirm the practical feasibility of this hybrid GA and MAS-based approach for dynamic AMR control in complex industrial settings.

Indexed as

Autonomous Mobile Robots (AMRs)dynamic path planningFlexible Manufacturing Systems (FMS)Multi-Agent Systems (MAS)

Identifiers

PMID40942746
PMCPMC12430893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.